Are Big Verdicts a Sign Johnson & Johnson Has 'Lost Its Way'?

, New Jersey Law Journal

   | 2 Comments

Plaintiffs lawyers haven been winning a steady stream of big products liability verdicts against Johnson & Johnson recently, and some have suggested the company's size makes it a bigger target for litigation—and also more willing to take cases to trial. But the heavy burden of litigation facing the company may have others questioning the company's direction and management.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Continue to Lexis Advance®

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

What's being said

  • Darren McKinney, American Tort Reform Association, Washington, DC

    No company in the U.S. acts as "negligently and recklessly" as shameless hucksters like Shanin Specter, the law firms of whom now collectively spend roughly a billion dollars a year on client-trolling advertising that scares half to death millions of users of perfectly safe medications and devices. Physicians regularly tell of situations in which their patients have seriously risked their health when they‘ve stopped taking medications after seeing the shysters‘ irresponsibly alarmist, junk-science commercials on cable TV. Why do we fund the Food and Drug Administration to the tune of nearly $5 billion annually (see fda.gov/downloads/AboutFDA/ReportsManualsForms/Reports/BudgetReports/UCM432650.pdf) if fast-talking plaintiffs lawyers, pursuing riches beyond their wildest dreams at everyone else‘s expense, can walk into any courtroom in America and persuade inexpert judges and juries to second-guess that regulatory body? If we want to have a serious national debate about the pricing of prescription drugs and medical devices, it must include the many billions of dollars spent each year on litigation ginned up by Mr. Specter‘s lawsuit industry, because surely those costs are passed along to consumers in the form of higher prices. -Darren McKinney, American Tort Reform Association, Washington, DC

  • Bob Moravsik

    J&J should use these verdicts to plan their conduct in the future. If damages can be traced to J&J AND they continue as they have been they should be sued out of existence. Litigation is a way of either changing behavior or stamping our bad companies. And yes, I‘m an attorney

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article #1202753661247

Thank you!

This article's comments will be reviewed.